Detail

Study ID: St Jude AML16

Title:

A PHASE II TRIAL OF EPIGENETIC PRIMING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

Description:
Title: A Phase II Trial of Epigenetic Priming in Patients with Newly Diagnosed Acute Myeloid Leukemia Description: A research study looking at comparing the effects of giving either of two drugs (Azacitidine or Decitabine) before the usual chemotherapy regimen for childhood Acute Myeloid Leukemia (AML).
Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD
Disease:
AML (Acute Myelogenic Leukemia)
Stage:
Phase II
Status:
Active - Open to Accrual